Why was interchangeability introduced?

Interchangeability was introduced primarily to encourage the use of high-quality generic drugs while simultaneously reducing costs for patients and the healthcare system. By allowing pharmacists to substitute a prescribed brand-name drug with a generic equivalent that is deemed interchangeable, the goal is to promote competition in the pharmaceutical market, leading to lower prices and greater access to necessary medications.

This is particularly beneficial in a healthcare system where the cost of medications can be a significant barrier for patients. Generic drugs, which are often less expensive than their brand-name counterparts, provide a way to achieve similar therapeutic outcomes at a reduced cost, thus supporting overall public health initiatives.

The focus on high-quality generics ensures that while cost savings are prioritized, patient safety and efficacy of medications remain paramount, aligning with regulatory standards in the pharmaceutical industry.